Figure 2.
Schema of the barriers to implementation of chimeric antigen receptor T cells for non–B-cell hematologic malignancies. Treg, T regulatory cells; M2 MΦ, M2 macrophage; MDSC, myeloid-derived suppressor cell.
Schema of the barriers to implementation of chimeric antigen receptor T cells for non–B-cell hematologic malignancies. Treg, T regulatory cells; M2 MΦ, M2 macrophage; MDSC, myeloid-derived suppressor cell.